Conversion of Osteoclasts into Bone-Protective, Tumor-Suppressing Cells
Osteoclasts are a driver of a vicious bone-destructive cycle with breast cancer cells. Here, we examined whether this vicious cycle can be altered into a beneficial one by activating Wnt signaling with its activating agent, BML284. The conditioned medium, derived from Wnt-activated RAW264.7 pre-oste...
Guardado en:
Autores principales: | Ke-Xin Li, Xun Sun, Bai-Yan Li, Hiroki Yokota |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6fe5fef72a444a3ab14d265d934101da |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Bone resorptive activity of osteoclast-like cells generated in vitro by PEG-induced macrophage fusion
por: Murillo,Andrea, et al.
Publicado: (2010) -
Punicalin Attenuates Breast Cancer-Associated Osteolysis by Inhibiting the NF-κB Signaling Pathway of Osteoclasts
por: Tao Li, et al.
Publicado: (2021) -
IL4/IL4R signaling promotes the osteolysis in metastatic bone of CRC through regulating the proliferation of osteoclast precursors
por: Qian Jin, et al.
Publicado: (2021) -
Flavonoids isolated from Tridax procumbens (TPF) inhibit osteoclasts differentiation and bone resorption
por: Mamun,Md. Abdullah Al, et al.
Publicado: (2015) -
Modulation of in vitro Osteoclast Activity Mediated by Different Doses of Parathyroid Hormone
por: Ginani,Fernanda, et al.
Publicado: (2017)